Feedback
Settings

Settings

Goto Application

108 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

tripalmitoyl cysteine or Pam3Cys and Epstein-Barr

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 11
1.20240050364IMMUNOSTIMULATORY METHOD
US - 15.02.2024
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No 18483662 Applicant ENA RESPIRATORY PTY LTD Inventor DAVID CHARLES JACKSON

This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.

2.20230414735NEOANTIGENS AND METHODS OF THEIR USE
US - 28.12.2023
Int.Class A61K 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
 Appl.No 18311158 Applicant BioNTech US Inc. Inventor Michael Steven Rooney

The field of the present invention relates to immunotherapeutic peptides, peptide binding agents, and their use, for example, in the immunotherapy of cancer.

3.20230405102NEOANTIGENS AND METHODS OF THEIR USE
US - 21.12.2023
Int.Class A61K 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
 Appl.No 18311155 Applicant BioNTech US Inc. Inventor Michael Steven Rooney

The field of the present invention relates to immunotherapeutic peptides, peptide binding agents, and their use, for example, in the immunotherapy of cancer.

4.20230355526LIPID COMPOSITIONS COMPRISING POLYNUCLEOTIDE ANTIGENS
US - 09.11.2023
Int.Class A61K 9/127
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
127Liposomes
 Appl.No 18028617 Applicant IMMUNOVACCINE TECHNOLOGIES INC. Inventor Marianne STANFORD

The present disclosure provides liposomal compositions comprising lipids, in particular phospholipids and cholesterol, a negatively charged biomolecule, such as a polynucleotide, an ionizable aminoglycoside, such as chitosan, and an oil-based carrier. The compositions can be used for delivery of the biomolecule to targeted cells. The disclosure also provides the use of the composition for the treatment or prevention of cancer or infectious disease or ailment ameliorated by humoral and cellular immune response. The compositions can also be used for expressing polypeptides encoded by the nucleic acid components in the targeted cells.

5.2023241320Neoantigens and methods of their use
AU - 19.10.2023
Int.Class C07K 4/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
4Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
12from animals; from humans
 Appl.No 2023241320 Applicant BioNTech US Inc. Inventor ROONEY, Michael Steven
The field of the present invention relates to immunotherapeutic peptides, peptide binding agents, and their use, for example, in the immunotherapy of cancer.
6.20230241207PROTEIN ANTIGENS AND USES THEREOF
US - 03.08.2023
Int.Class A61K 39/245
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
245Herpetoviridae, e.g. herpes simplex virus
 Appl.No 16500707 Applicant Neon Therapeutics, Inc. Inventor Michael Steven Rooney

The field of the present invention relates to immunotherapeutic peptides, peptide binding agents, and their use, for example, in the immunotherapy of cancer.

7.20230141371CORONAVIRUS VACCINES AND METHODS OF USE
US - 11.05.2023
Int.Class A61K 39/215
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
 Appl.No 17912841 Applicant BioNTech US Inc. Inventor Richard B. Gaynor

Compositions and methods for the prevention and/or treatment of a viral infection, in particular of the Coronaviridae family.

8.WO/2023/052842SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY
WO - 06.04.2023
Int.Class A61K 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
 Appl.No PCT/IB2022/000557 Applicant BIOVAXYS INC. Inventor PICARD, Valerie
The present application relates generally to methods for treating tumors, and in particular to methods for using peptides of both survivin and MAGE-A9 in dual-targeted immunotherapy that generates targeted T cell response against these two tumor antigens.
9.2022354218SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY
AU - 06.04.2023
Int.Class A61K 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
 Appl.No 2022354218 Applicant IMMUNOVACCINE TECHNOLOGIES INC. Inventor BERGERON, Alain
10.WO/2023/049272CORONAVIRUS VACCINES AND METHODS OF USE
WO - 30.03.2023
Int.Class A61K 39/215
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
 Appl.No PCT/US2022/044400 Applicant BIONTECH SE Inventor GAYNOR, Richard B.
Compositions and methods for the prevention and/or treatment of a viral infection, in particular of the Coronaviridae family.
# -